Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Abituzumab × Clear all

NCT00958477 2017-08-02

A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Phase 1 Completed

26 enrolled 44 charts

Prostatic Neoplasms